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ABSTRACT
Objective: Analyzing the potential of S. salivarius isolated from the saliva and tongue dorsum of adults to inhibit the growth of Fusobacterium 
nucleatum.
Methods: Polymerase chain reaction, deferred antagonism test, and well-diffused agar test.
Results: Inhibition of the growth F. nucleatum by S. salivarius isolated from the tongue dorsum (p>0.05). No inhibition to the growth of F. nucleatum 
by S. salivarius isolated from the saliva. No inhibition to the growth of F. nucleatum by the protein produced by S. salivarius.
Conclusions: The growth of F. nucleatum was not inhibited by S. salivarius isolated from the saliva but by S. salivarius isolated from the dorsum of the 
tongue.
Keywords: Streptococcus salivarius, Fusobacterium nucleatum, Probiotic.
INTRODUCTION
For years, a general decrease in the effectiveness of antibiotics to 
cure infections has been occurring globally at an increased pace [1], 
leading to the development of other approaches, including a natural 
alternative, probiotic agents, to address this problem. Probiotics are 
defined by the World Health Organization as living microorganisms 
that can be beneficial to their host’s health [2]. Various studies 
have shown that isolated oral probiotics can prevent caries and 
the formation of biofilm plaque and can treat pharyngitis and 
halitosis [2], which has led to their use as treatments and prevention 
methods in oral and dental health. Of existing oral bacteria species, 
the Streptococcus genus has proved to have beneficial effects on 
oral infections [3]. Probiotics work by inhibiting the adhesion of 
pathogens to the host’s tissue, stimulating and modulating the 
immune system, and killing or inhibiting the growth of pathogens by 
producing products toxic to them, including bacteriocins, which are 
peptides or antimicrobial proteins produced by bacteria that inhibit 
the growth of or kill other bacteria without endangering themselves. 
Streptococcus salivarius produces Bacteriocin-like inhibitory 
substance, a bacterial product that has an inhibitory effect similar to 
that of a bacteriocin [3].
S. salivarius is an oral microbiotic organism abundant in healthy 
human beings that play a major role in maintaining a balanced 
oral ecosystem. In healthy human beings, S. salivarius is the main 
component in biofilm that forms on the buccal mucosa, tongue, 
dorsum epithelial, and pharynx mucosa. Some strains of S. salivarius 
on the tongue release bacteriocins that are toxic to oral flora bacteria 
and that change characteristics from commensal to pathogenic [4,5]. 
The literature shows S. salivarius as toxic to the oral streptococci 
involved in tooth decay, including Streptococcus mutans, Streptococcus 
sobrinus, and Streptococcus pyogenes, and to the pathogens involved 
in periodontitis [6]. Fusobacterium nucleatum is an oral organism that 
can be pathogenic to periodontal tissue, as it invades oral epithelial 
cells and facilitates the infiltration of non-invasive bacteria to form a 
biofilm on periodontal tissue [7]. Therefore, early elimination of the 
bacteria that cause periodontal disease can delay its development. 
The most common periodontal disease is periodontitis, an infection 
in the tooth-supporting structure caused by inflammation, which 
causes a progressive destruction in the periodontal ligament and 
alveolar bone structure due to the formation of plaque, calculus, and 
periodontal pockets. One of the major causes of periodontal disease 
is bacterial accumulation, which triggers the formation of microbial 
plaque [7].
Because of its relatively limited spectrum, protein produced by 
S. salivarius could be a natural alternative to antibiotics [3]. Even though 
the probiotic effect of S. salivarius has been known, to date no studies 
have addressed the potential of protein secreted by S. salivarius isolated 
from the dorsum of the tongue and from the saliva to inhibit the growth 
of F. nucleatum. This study aimed to analyze the potential of protein 
and other molecules secreted by S. salivarius isolated from the dorsum 
of the tongue and the saliva of healthy adults to inhibit the growth of 
F. nucleatum.
METHODS
Subject selection and preparation
Participants were selected by comparing the oral condition of each 
potential participant to the inclusion criteria. Ten participants who met 
these criteria were given an explanation of the study and were asked 
to sign an informed consent form agreeing to participate. Participants 
were asked not to consume any food for 3 hrs before sample collection 
and to brush their teeth before sample collection.
Sampling the saliva and the dorsum of the tongue
Samples were collected in the morning. Immediately before collection, 
participants were asked to rinse their mouths with water to eliminate 
food debris, and collection was delayed 10 minutes after rinsing to 
avoid dilution of saliva with the rinse water. Then, 10 ml of saliva was 
collected after stimulation with Parafilm M, in which participants were 
instructed to chew for 10 minutes before their saliva was collected 
into sterilized vials, which were sealed and refrigerated at 4°C until 
use. Before the collection of isolated samples of the dorsum of the 
tongue, each participant’s tongue was isolated using a sterilized cotton 
roll. Sampling was done by moving a citobrush from the circumvallate 
papillae to the tip of the tongue. Each citobrush containing a sample 
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was placed into a vial with phosphate buffered saline (PBS) of pH 7.2 
and refrigerated at 4°C until used.
Identifying S. salivarius
The samples of saliva and isolated dorsum of the tongue were cultured 
on mannitol salt agar (MSA) medium to isolate the S. salivarius 
colonies [8]. The medium containing the target bacteria was stored in 
anaerobic jars, subjected to mixed gas for 2 minutes, and then incubated 
at 37°C for 24 hrs. In addition, colony morphology was identified by 
observing the size and surface consistency of each colony for softness 
and smoothness (Fig. 1) [9]. Colonies identified by this observation 
were confirmed as S. salivarius using the polymerase chain reaction 
(PCR) technique, with S. salivarius ATCC 13419 serving as a positive 
control and SalAUS (5’-GTAGAAAATATTTACTACATACT) and SalADS 
(5’-GTTAAAGTATTCGTAAAACTGATG) serving as primers [10]. Colonies 
confirmed by PCR were then grown on Columbia blood agar, given 
mixed gas for 2 minutes, and incubated at 37°C for 24 hrs.
The results of this CPR amplification were analyzed using 1% agarose 
subjected to electrophoresis for 30 minutes at 100 V. S. salivarius 
colonies were identified by the appearance of a DNA band of 118 bp. 
Colonies identified as S. salivarius were provided with glycerol stock 
and stored at −80°C. Cultivation was also conducted on brain-heart 
infusion (BHI) agar medium and BHI liquid for 18 hrs.
Identifying and calculating S. salivarius protein concentrations
The results of the liquid-medium cultivation were centrifuged. The 
resulting pellets were separated from spent medium using cell 
lysate buffer and centrifuged. Both the pellets and the spent medium 
were analyzed using sodium dodecyl sulfate-polyacrylamide gel 
electrophoresis (SDS-PAGE) (150 V, 80 mA, 60 minutes) and colored 
using Coomassie blue. SDS-PAGE identified 4 participants with similar 
protein profiles based on the appearance of bands having sizes up to 70, 
40, and 10 kDa (Fig. 2).
The Bradford method was used to calculate concentrations of protein 
that had the same molecule mass [11], which identified that on the 
whole cell, the concentration of protein produced by S. salivarius from 
isolated saliva was 20,625 µg/ml; from isolated dorsum of the tongue, 
20,313 µg/ml; and from ATCC 13419, 14,622 µg/ml. On the spent 
medium, the concentration of protein produced by S. salivarius from 
isolated saliva was 28,263 µg/ml; from the isolated dorsum of the 
tongue, 27,972 µg/ml; and from ATCC 13419, 18,127 µg/ml. Colonies of 
S. salivarius with similar profiles were placed in Eppendorf tubes filled 
with 30% glycerol and stored frozen at −80°C as stock.
Deferred antagonism testing to analyze inhibitory potential of 
S. salivarius
Clinical S. salivarius and S. salivarius ATCC 13419 (control) were diluted 
into 4 concentrations: 100%, 10%, 1%, and 0.1%, each of which was 
inoculated on a 1-cm band on BHI agar. The agar plate was placed 
inside an anaerobic jar, given mixed gas, and incubated at 37°C for 24 
hrs. Likewise, F. nucleatum 10,593 was cultured on BHI agar medium, 
placed inside an anaerobic jar, given mixed gas, and incubated at 37°C 
for 24 hrs. After 24 hrs, bacteria visible on the agar’s surface were 
wiped with a glass slide. Then, the agar’s surface was sterilized with 
chloroform for 30 minutes by placing the agar plate upside down 
against a circle of filter paper soaked in chloroform, with the assumption 
that the bacteria on the agar’s surface would die and those inside the 
agar would live. After 30 minutes, the plate was aired for 15 minutes 
to eliminate remaining chloroform. One colony of F. nucleatum was 
placed into an Eppendorf tube filled with soft agar and centrifuged to 
homogenize it. A cotton bud was used to spread the F. nucleatum mixed 
with soft agar perpendicular to S. salivarius that had been cleaned. Each 
procedure was performed twice. Then, the agar plate was placed inside 
an anaerobic jar, given mixed gas, and incubated at 37°C for 24 hrs 
preparatory to identifying the inhibitory zone of F. nucleatum growth.
Analyzing the inhibitory potential of S. salivarius protein
A 2-inoculating loops colony of F. nucleatum was placed into an Eppendorf 
tube filled with PBS and centrifuged until homogenated. Then, 100 ml of 
BHI agar was sterilized and cooled to 55°C. F. nucleatum was diluted with 
PBS and then inoculated into the liquid BHI agar. After being placed on an 
orbital shaker for 30 seconds, the BHI agar was poured into a Petri dish. 
Once the agar hardened, 4 wells were made in it, each 4 mm in diameter. 
Protein was placed into each well, and the dish was incubated at 37°C 
for 24 hrs, at which time, the distance between each well’s edge and the 
edges of the bacteria colonies was observed and measured.
Data analysis
Data analysis was performed by comparing the number of participants 
who harbored S. salivarius colonies in both their isolated saliva and isolated 
dorsum of the tongue with those who harbored no colonies in either 
isolated source. This was done using Fisher’s test (F-test). In addition, a 
one-way ANOVA post hoc test was conducted to compare the mean values 
of the inhibitory zones of S. salivarius and its secreted protein against the 
growth of F. nucleatum on each isolated source. Furthermore, the inhibitory 
potential of S. salivarius and its secreted protein on each concentration was 
analyzed using a paired t-test. Finally, a one-way ANOVA test was used to 
compare the mean value of the inhibitory zone of S. salivarius with the 
mean value of the inhibitory zone of its secreted protein.
RESULTS
Identification of S. salivarius was conducted by comparing the 
morphology of clinical S. salivarius with that of a control, S. salivarius 
ATCC 13419, which was grown on MSA medium. Of the 10 participants, 
6 from each isolated sample had S. salivarius colonies with similar 
morphologies: Large, sticky, and mucoid. PCR test was conducted on 
these six participants to confirm that the colonies were S. salivarius, 
which was done by observing the fragment band of 118 bp. Fig. 3 shows 
the results of the PCR test (Table 1).
After S. salivarius was isolated from the isolated sources, the interaction 
of S. salivarius from four subjects who had protein profiles similar to 
Fig. 1: Morphology of Streptococcus salivarius culture on Mitis 
Salivarius agar medium
Fig. 2: Profile of protein Streptococcus salivarius based on sodium 
dodecyl sulfate-polyacrylamide gel electrophoresis analysis
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those of F. nucleatum 10,593 was tested using a deferred antagonism test. 
Analysis was conducted by comparing the means of the inhibitory zone of 
F. nucleatum growth of each concentration from each isolated source. The 
results of this test could be interpreted for only one of the four participants. 
Therefore, this stage of the study and the next one used a sample from 
only one participant. For both the isolated dorsum of the tongue and the 
control, the mean values of the zone of inhibition of F. nucleatum growth 
differed significantly from that of isolated saliva. The mean value of the 
zone of inhibition of isolated saliva could not be compared with that of the 
control because both had the same results (Fig. 4).
The value of the inhibitory zone of the isolated dorsum of the tongue 
was significantly larger than those for both isolated saliva and the 
control. However, the values of the inhibitory zone of the isolated saliva 
and the control did not differ significantly from each other. In fact, on 
each concentration of each isolate, the mean value of the inhibitory 
zone of S. salivarius differed slightly, but not significantly. The potential 
of protein secreted by S. salivarius to inhibit the growth of F. nucleatum 
was tested using the well-diffused agar method. Tables 2 and 3 show 
that for each isolated source, the mean value of the inhibitory zone 
around the well and at all concentration levels was 0 mm.
A dense colony of F. nucleatum grew inside the agar but did not reach 
the surface, so microscopic observations were made around the wells 
to confirm the presence of the colonies (Fig. 5). These observations 
confirmed that circles of colonies were spread throughout the agar, 
indicating that there was no inhibition of colony growth inside the agar.
DISCUSSION
This study was conducted to analyze the potential of S. salivarius and 
its secreted protein to inhibit the growth of F. nucleatum isolated from 
both the saliva and the dorsum of the tongue. The results showed that 
Fig. 3: Polymerase chain reaction test results for Streptococcus 
salivarius colonies, isolated saliva, and isolated dorsum of the 
tongue. Sal: Isolated saliva. L: Isolated dorsum of the tongue. 
ATCC: S. salivarius ATCC 13419
Fig. 4: Potential of Streptococcus salivarius based on isolate to 
inhibit the growth of Fusobacterium nucleatum as measured using 
the deferred antagonism test
Table 1: Identifying S. salivarius from clinical isolated sources
Isolated source S. salivarius
 + (%)  – (%)
Saliva 6 (60) 4 (40)
Tongue 6 (60) 4 (40)
S. salivarius: Streptococcus salivarius
Fig. 5: (a and b) Microscopic images of Fusobacterium nucleatum 
colonies inside agar
ba
Table 2: Mean value of inhibitory zone for each concentration on each isolated whole cell, as measured using the well-diffused agar 
method
Description Results of culture based on protein concentration
Concentration of protein S. salivarius ATCC 13419 Control 14.62 µg/ml 1.46 µg/ml 1.46×10−1 µg/ml 1.46×10−2 µg/ml
Mean value of inhibitory zone 0 mm 0 mm 0 mm 0 mm 0 mm
Concentration of clinical protein S. salivarius (saliva) Control 20.62 µg/ml 2.06 µg/ml 2.06×10−1 µg/ml 2.06×10−2 µg/ml
Mean value of inhibitory zone 0 mm 0 mm 0 mm 0 mm 0 mm
Concentration of clinical protein S. salivarius (dorsum of the 
tongue)
Control 20.31 µg/ml 2.03 µg/ml 2.03×10−1 µg/ml 2.03×10−2 µg/ml
Mean value of inhibitory zone 0 mm 0 mm 0 mm 0 mm 0 mm
S. salivarius: Streptococcus salivarius
Table 3: Mean value of inhibitory zone for each concentration on each isolated spent medium, as measured using the well-diffused agar 
method
Description Results of culture based on protein concentration
Concentration of protein S. salivarius ATCC 13419 Control 18.12 µg/ml 1.81 µg/ml 1.81×10−1 µg/ml 1.81×10−2 µg/ml
Mean value of inhibitory zone 0 mm 0 mm 0 mm 0 mm 0 mm
Concentration of clinical protein S. salivarius (saliva) Control 28.26 µg/ml 2.82 µg/ml 2.82×10−1 µg/ml 2.82×10−2 µg/ml
Mean value of inhibitory zone 0 mm 0 mm 0 mm 0 mm 0 mm
Concentration of clinical protein S. salivarius (dorsum of the 
tongue)
Control 27.97 µg/ml 2.79 µg/ml 2.79×10−1 µg/ml 2.79×10−2 µg/ml
Mean value of inhibitory zone 0 mm 0 mm 0 mm 0 mm 0 mm
S. salivarius: Streptococcus salivarius
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of 10 participants, 6 had S. salivarius in both sample sources (saliva and 
dorsum of the tongue). The results aligned with those of a previous 
study, which found that S. salivarius was a pioneer colony in the oral 
cavity and remained there as predominant bacteria as long as the 
human host lived [12]. That study concluded that S. salivarius could be 
isolated from the human oral cavity, especially in samples of saliva and 
dorsum of the tongue. However, that study found minimal numbers of 
S. salivarius colonies. The diets of participants could be a factor in this, 
as diet can influence changes in microbiotic composition, depending 
on the basic capacity of each species to use the diet substrate [12]. 
S. salivarius needs organic components and nutrients such as sucrose 
for microbial growth [13]. Therefore, eliminating sucrose from the 
diet could drastically decrease the amount of S. salivarius in the saliva. 
Ogawa et al. found that S. salivarius needs a certain amount of energy to 
grow and develop colonies [12]. This energy comes from sucrose, which 
is degraded into fructose with the help of an extracellular enzyme called 
fructosyltranferase, which is secreted by S. salivarius.
Besides diet, factors that influence growth of S. salivarius in the human 
oral cavity include components of enzymes in the saliva, including 
lysozyme, lactoperoxidase, and amylase, all of which have antibacterial 
activity [13] that might decrease the growth of S. salivarius to the point 
that colonies are undetected when grown on MSA medium. The present 
study used multiple isolated sources and concentrations to analyze the 
potential of S. salivarius and its secreted protein to inhibit the growth 
of F. nucleatum. A one-way ANOVA test showed no significant difference 
between either the inhibitory zones of isolated dorsum of the tongue 
and saliva or between the inhibitory zones of any of the sources and 
the control (S. salivarius ATCC 13419). Likewise, a post hoc test of 
each concentration of each isolate and the control found no significant 
differences, indicating that the inhibitory potential of S. salivarius, 
whether from one of the isolated sources or from the control, was not 
dependent on the concentration of the bacteria.
To function properly, lantibiotic must bond with a lipid II precursor 
in the peptidoglycan. Gram-negative bacteria have three layers of cell 
membrane: The outer membrane, a thick layer of peptidoglycan in 
the periplasmic space, and an inner membrane. The outer membrane 
acts as a barrier to stop macromolecules, including bacteriocins, 
from entering [14]. Therefore, to reach the peptidoglycan, products 
of S. salivarius must penetrate the outer membrane of Gram-negative 
bacteria. An external agent called a permeabilizer can destroy the 
integrity of this outer membrane [15]. Lactic acid is a permeabilizer, and 
S. salivarius, as lactic acid bacteria, can produce lactic acid. Therefore, in 
the present study, S. salivarius was assumed to be able to produce lactic 
acid that would destroy the outer membrane of F. nucleatum, allowing 
lantibiotic to bond with the lipid II precursor on the peptidoglycan, 
create pores in the F. nucleatum membrane, inhibit the cell membrane’s 
biosynthesis, and destroy the target bacteria.
The present study formed inhibitory zones differently from those in 
MacDonald’s study, which found no inhibition against the growth of 
F. nucleatum [16]. However, that study found that although there was no 
inhibition against the growth of F. nucleatum, there was coaggregation 
between S. salivarius and F. nucleatum. This difference in results might 
be caused by the characteristics of salivaricin. MacDonald’s study used 
S. salivarius K12 and M18, reas the present study used S. salivarius 13,491 
(control) and a clinical strain [16]. One of the lantibiotics secreted by 
S. salivarius K12 and M18 is salivaricin B, which instead of forming pores 
on the cell’s membranes, resists the transglycosylation that leads to 
inhibition of the cell wall’s biosynthesis [17]. That was why in the study, 
salivaricin appeared only to reduce the thickness of the cell walls. In that 
study, after 24 hrs, the target cell had undergone only partial lysis.
In the present study, purification was not conducted to encourage a 
specific antibiotic, so it could not be determined which type of lantibiotic 
would be produced by any particular strain. Likewise, the present study 
did not conduct microscopic tests of the F. nucleatum after exposure to 
S. salivarius, so data on changes to the structure of the cell layers cannot 
be provided. However, given the differences in the results between 
McDonald’s study and the present one, it can be assumed that the strain 
used by the latter produced a type of lantibiotic that produced pores 
and inhibited the growth of the target bacteria. Paired t-test conducted 
on the inhibition zones produced by the isolated dorsum of the tongue 
and by S. salivarius 13,419 (control) showed that the clinical S. salivarius 
strain had a larger inhibition zone than S. salivarius did, even though 
the difference was not statistically significant (p>0.05). However, the 
inhibition zone produced by isolated saliva could not be compared 
statistically with that produced by S. salivarius 13,419 because the 
results of both were the same, with neither forming an inhibition zone.
The results of the present study also were aligned with those of 
another previous study that identified three receptors on the surface 
of S. salivarius [18]. The first receptor mediates the host’s adhesion 
and aggregation, including aggregation of saliva and adhesion to 
buccal epithelial cells. The second receptor functions in coaggregation 
with Veillonella alcalescens VI, and the third receptor functions in 
coaggregation with Fusobacterium nucelatum LF. That study found that 
the receptors on both clinical and wild-type strains functioned well 
in vitro, meaning that they could adhere to the buccal surface, the teeth, 
and the dorsum of the tongue, as well as coaggregate with Veillonella 
and F. nucleatum. That study found no adhesion to either epithelial cells 
or saliva and no coaggregation with Veillonella. To further analyze the 
microbial activity of S. salivarius, the present study conducted another 
test of the inhibition potential of its secreted protein, this time using the 
well-diffused agar method. The bacteria that produced the protein were 
grown on liquid medium BHI broth. After 24 hrs, protein produced by 
the bacteria on whole cells was harvested using the cell-lysate method, 
while protein on the spent medium was harvested using centrifugation.
The results of this test showed no potential of S. salivarius from either 
saliva or from the dorsum of the tongue to inhibit the growth of 
F. nucleatum in any concentration. These results supported the theory of 
Barbour et al. and Ross et al., which states that more bacteriocins would 
be produced by S. salivarius if the bacteria were grown on a solid medium 
[19]. In general, bacteriocins were not expressed and did not show 
inhibition activity when the bacteria were grown on liquid medium. 
However, liquid medium could be used if the method used to harvest 
the protein was the auto-induction method [19]. This theory was also 
supported by a study by Barbour and Philip, which found that regulating 
lantibiotic production involved peptides secreted as molecules that play 
a role in bacterial communication [8]. These peptides accumulate in an 
environment during bacterial growth, and when they reach a certain 
concentration, lantibiotic production is induced in high concentration. 
However, production of salivaricin from the S. salivarius strain did 
not guarantee that the bioactive molecule would be well expressed. 
Therefore, in the present study, the auto-induction method was not 
used, and the possibility that peptide-molecule concentration would not 
reach a point sufficient to induce lantibiotic production was assumed to 
be one of the causes of the unexpressed protein of S. salivarius when it 
was tested using a bacterial indicator.
Another factor that might influence the results of the present study 
is the possibility that the lantibiotic could not bond with the lipid II 
precursor on the peptidoglycan. In general, lantibiotic interferes with 
the integrity of the cytoplasmic membrane by forming pores and 
inhibiting the biosynthesis of cell walls [17,19]. As explained previously, 
lantibiotic can work on Gram-negative bacteria only if the bacteria’s 
outer membrane is compromised [20], which can be accomplished only 
by lantibiotic that is relatively large (1800-4600 Da) [21]. To penetrate 
the outer membrane, a permeabilizer is needed, such as lactic acid 
produced by S. salivarius. However, in the present study, F. nucleatum 
was exposed only to protein produced by S. salivarius. Therefore, there 
was no fermentation of lactic acid to enable destruction of the outer 
membrane, so the lantibiotic could not act on the F. nucleatum. The 
present study assumed that without a permeabilizer, produced either 
by S. salivarius or another substance acting as one, lantibiotic could not 
influence the growth of F. nucleatum because it would not be capable 
 Nurfitri et al. 
Int  J  App  Pharm,  Vol  9, Suppl 1, 2017, 
12
of penetrating the outer membrane to reach the peptidoglycan layer. 
Because of time limitations and constraints on the materials available, 
the present study did not use either the purification method or the 
auto-induction method to harvest a certain lantibiotic. Each class of 
lantibiotic has a different mechanism. This constraint on the study’s 
method prevented further elaboration of differences in the mechanism 
of inhibition between S. salivarius and F. nucleatum. Therefore, studies 
should investigate lantibiotic protein that is produced using a clinical 
strain from both isolated saliva and isolated dorsum of the tongue.
CONCLUSION
In general, the present study concluded that S. salivarius had the 
potential to inhibit the growth of in vitro F. Nucleatum. However, this 
inhibitory potential differed, depending on whether the S. salivarius 
came from the participant’s saliva or dorsum of the tongue. However, 
the source of the S. salivarius made no difference in the ability of the 
protein it produced to inhibit the growth of F. nucleatum. Suggestions 
for further studies include the following: (1) Purifying lantibiotic 
produced by S. salivarius; (2) acquiring a more specific type of 
lantibiotic; (3) analyzing S. salivarius’s inhibitory potential using 
samples isolated from both saliva and the dorsum of the tongue and 
using S. salivarius K12 and M18 as positive controls; (4) analyzing the 
inhibitory potential of protein produced by S. salivarius when combined 
with a permeabilizer; and (5) analyzing the antimicrobial activity of a 
clinical strain of S. salivarius on other oral-bacterial pathogens.
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